GEMCAP
GemCap is an investment holding company that recently invested in other disruptive digital technology platforms such as PayProp, Consumer Friend and InfoSlips.
GEMCAP
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF LetsEncrypt Apache Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS Google Maps API MailChimp SPF Hetzner
Similar Organizations
Greencap Equity
Greencap Equity operates as an investment holding company.
Tadvest
Tadvest is an investment holding company.
Zeder
Zeder is an investment holding company
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-08-31 | Linebooker | Linebooker acquired by GemCap | N/A |
More informations about "GemCap"
Gemcitabine and capecitabine (GemCap) | Cancer Research UK
GemCap - Crunchbase Investor Profile & Investments
GemCap is a lending firm that offers asset-based loans, term loans, and factoring facilities for small and medium-sized businesses. San Antonio, Texas, United States; 11-50; Venture Debt …See details»
Efficacy and safety of gemcitabine-capecitabine …
Dec 3, 2021 The question of whether GemCap can achieve a better benefit than Gem alone is still unclear. We performed the present meta-analysis to compare the efficacy and tolerability of GemCap vs Gem alone for pancreatic cancer …See details»
Real-world outcomes of adjuvant gemcitabine versus …
May 9, 2022 Recently, updated 5-year follow-up data from the ESPAC-4 trial have also demonstrated an OS benefit associated with GemCap (median OS = 27.7 months for the GemCap group and 26.0 months for the Gem group; HR = …See details»
Comparison of adjuvant gemcitabine and capecitabine …
Mar 11, 2017 We were also directly involved in the GemCap trial which compared the combination of gemcitabine and capecitabine to gemcitabine alone in advanced and metastatic pancreatic cancer. In the adjuvant setting, the role …See details»
Real-world evidence of adjuvant gemcitabine plus capecitabine …
Dec 22, 2021 9 Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), The Netherlands. PMID: 34935139 ... 95% CI 0.57-0.92, logrank p=0.009). Survival …See details»
Efficacy of GV1001 with gemcitabine/capecitabine in previously
Oct 30, 2023 GemCap treatment included gemcitabine (1000 mg/m 2, 30 min intravenous infusion, on days 1, 8 and 15) and capecitabine (830 mg/m 2 orally twice daily) for 21 days per …See details»
Expanded phase II trial of gemcitabine and …
Aug 31, 2007 The GemCap regimen has consistenly shown promising results, as demonstrated by our expanded phase 2 trial, which to our knowledge is 1 of the largest trials published to date regarding this disease, as well as by other …See details»
Gemcitabine plus capecitabine in unselected patients with …
Objectives: Gemcitabine in combination with capecitabine (GEMCAP) is a ... 51% of patients had metastatic disease; and 80% were of World Health Organization performance status 0 or 1. …See details»
Capecitabine and Gemcitabine (CapGem, CG, GemCap) for …
Abstract. The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues …See details»
Gemcitabine plus capecitabine compared with gemcitabine alone …
Jun 1, 2007 Purpose: This phase III trial compared the efficacy and safety of gemcitabine (Gem) plus capecitabine (GemCap) versus single-agent Gem in advanced/metastatic pancreatic …See details»
Long-term results and recurrence patterns from SCALOP: a phase …
Apr 4, 2017 Following 12 weeks of induction GEMCAP chemotherapy (three cycles: GEM 1000 mg m−2 days 1, 8, 15; CAP 830 mg m−2 days 1–21 q28 days) patients with stable/responding …See details»
Gemcitabine and Capecitabine chemotherapy - Pancreatic Cancer …
In this instance, GemCap is made up of Gemcitabine and Capecitabine.. Capecitabine, also known as Xeloda ®, stops cancer cells from dividing and is the oral version of the drug 5 …See details»
Efficacy and safety of gemcitabine plus capecitabine in the …
Background: Gemcitabine combined the oral fluoropyrimidine capecitabine (GemCap) is an active antitumor therapy in the treatment of advanced or metastatic pancreatic cancer, and has been …See details»
Adjuvant gemcitabine (GEM) versus gemcitabine plus capecitabine …
Jan 19, 2022 In multivariate analysis, adjuvant GEMCAP was significantly associated with better OS compared to adjuvant GEM (adjusted HR 0.64, 95% CI, 0.44-0.91, p = 0.014). Otherwise, …See details»
Gemcitabine plus capecitabine in elderly patients with advanced ...
Introduction: Gemcitabine in combination with capecitabine (GEMCAP) is a treatment option for patients with advanced pancreatic cancer (APC), ... and 80% were of World Health …See details»
Efficacy and safety of gemcitabine-capecitabine combination
Dec 3, 2021 Background: Recent randomized controlled trials revealed the combination of gemcitabine and capecitabine (GemCap) regime shows promising efficacy in pancreatic …See details»
GemCap - Macmillan Cancer Support
GemCap is named after the chemotherapy drugs used: Gem – gemcitabine Cap – capecitabine GemCap is used to treat pancreatic cancer.It may sometimes be used to treat other cancers. It …See details»
Real‐world evidence of adjuvant gemcitabine plus capecitabine vs ...
Dec 22, 2021 In this first nationwide study to compare adjuvant GEMCAP with adjuvant GEM in PDAC in daily clinical practice, adjuvant chemotherapy with GEMCAP was associated with a …See details»